Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,463 | -17,624 | -43,133 | -28,318 | -18,146 |
| Depreciation Amortization | 107 | -84 | 291 | 364 | 259 |
| Accounts payable and accrued liabilities | -905 | -1,383 | 1,961 | 655 | 1,421 |
| Other Working Capital | 2,349 | -631 | -5,024 | -6,912 | -957 |
| Other Operating Activity | 5,448 | 3,335 | 789 | 1,162 | -246 |
| Operating Cash Flow | $-29,464 | $-16,387 | $-45,116 | $-33,049 | $-17,669 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,229 | -1,705 | -2,337 | -1,737 | -1,148 |
| Purchase Of Investment | -127,302 | -41,131 | -208,901 | -57,774 | N/A |
| Sale Of Investment | 157,107 | 71,365 | 8,000 | N/A | N/A |
| Investing Cash Flow | $25,576 | $28,529 | $-203,238 | $-59,511 | $-1,148 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 15,000 | 15,000 | 15,000 |
| Common Stock Issued | 356 | 22 | 187,352 | 187,343 | 175 |
| Other Financing Activity | -568 | 0 | 79,906 | 81,909 | 44,427 |
| Financing Cash Flow | $-212 | $22 | $282,258 | $284,252 | $59,602 |
| Beginning Cash Position | 35,891 | 35,891 | 1,987 | 1,987 | 1,987 |
| End Cash Position | 31,791 | 48,055 | 35,891 | 193,679 | 42,772 |
| Net Cash Flow | $-4,100 | $12,164 | $33,904 | $191,692 | $40,785 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,464 | -16,387 | -45,116 | -33,049 | -17,669 |
| Capital Expenditure | -4,229 | -1,705 | -2,337 | -1,737 | -1,148 |
| Free Cash Flow | -33,693 | -18,092 | -47,453 | -34,786 | -18,817 |